Key result
Warfarin patients report highest psychological quality of life with non-CVD comorbidities linked to health satisfaction.
Why the study?
The effect of anticoagulation control on overall Health-Related Quality of Life in patients taking warfarin in Malaysia had not yet been explored.
What is the Health-Related Quality of Life and its associated factors among patients on warfarin in Malaysia?
Cross-Sectional (n=319)
What is the Health-Related Quality of Life and its associated factors among patients on warfarin in Malaysia?
Patients on warfarin in Malaysia reported better psychological quality of life compared to physical, social, and environmental domains, with non-cardiovascular comorbidities significantly affecting overall health satisfaction.
Demographic and comorbidity factors associate with HRQoL domains in Malaysian warfarin patients; leaves open anticoagulation control effects and needs prospective confirmation.
The effect of anticoagulation control on overall Health-Related Quality of Life (HRQoL) in patients taking warfarin in Malaysia has not been explored yet. Therefore, this study aimed to evaluate HRQoL among patients on warfarin in Malaysia. HRQoL among patients on warfarin was measured using WHOQOL-BREF (World Health Organization Quality of life Assessment: Brief Version). Descriptive and inferential statistical analysis was done using Statistical Package for the Social Sciences (SPSS) version 22. Out of 319 patients, more female patients were observed than the males (n = 221, 69.3%, and n = 98, 30.7% respectively). Mean scores for the physical (61.14 ± 15.96), psychological (68.58 ± 16.11), social (63.55 ± 27.06) and environmental domains (62.78 ± 17.58) were observed. Statistically, a significant association was found between the comorbidities other than CVDs with health satisfaction (p = 0.002), physical (p = 0.001), psychological (p < 0.001), social (p = 0.003) and environmental domains of the WHOQOL-BREF. A weak positive correlation between overall health satisfaction and the social domain (r = 0.153) and a moderate positive correlation between the physical and environmental domains (r = 0.628) of the WHOQOL-BREF were observed. Patients had overall better perceived HRQoL scores in the psychological domain as compared with the rest of the domains of the WHOQOL-BREF. Age, gender, employment status, education level, the indication of use and duration of warfarin therapy associated with overall perceived HRQoL.
No takes yet. Share an insight, caveat, or question.
Iqbal et al. (2020) conducted a cross-sectional in Patients on warfarin (n=319). Warfarin therapy was evaluated on Health-Related Quality of Life (HRQoL) measured using WHOQOL-BREF. Among patients on warfarin, HRQoL scores were highest in the psychological domain (68.58 ± 16.11), and non-CVD comorbidities were significantly associated with health satisfaction (P=0.002).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: